Search Results 211-220 of 7732 for Fungicides

1. Trial of Eflornithine Plus Sulindac in Patients with Familial Adenomatous Polyposis (FAP) - Mayo Clinic

   This includes: 1) FAP related disease progression indicating the need for excisional intervention involving the colon, rectum, pouch, duodenum and/or 2) ...

2. Pet allergy - Doctors and departments - Mayo Clinic

   Family pet making you sneeze? Find out about diagnosis, treatment and handy household tips for relieving bothersome pet allergy symptoms.

3. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

4. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

   Understanding of how best to treat inflammatory bowel disease (IBD) has evolved over the last ten years. Evidence now suggests that the most effective ...

5. Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination with Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer - Mayo Clinic

   Dabrafenib is a potent and selective inhibitor of BRAF kinase activity. This is a Phase II, non-randomized, open-label study to assess the efficacy, safety, and ...

6. Immune-mediated adverse events - Mayo Clinic

   CT chest scan, PET-CT scan and transbronchoscopic biopsy indicating immune-mediated adverse events. Share · Tweet . IMG-20400457.

7. A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant - Mayo Clinic

   About this study. The purpose of this study is to determine the effect of ixazomib citrate maintenance therapy on progression-free survival (PFS), ...

8. A Study to Assess the Effectiveness and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

   The primary purpose of this study is to evaluate the effectiveness of REGN3500 monotherapy compared with placebo treatment in adult patients with moderate-to- ...

9. Anaphylaxis - Doctors and departments - Mayo Clinic

   Anaphylaxis, a severe allergic reaction, is an emergency. Learn who's at risk, what to watch for and what to do when it occurs.

10. An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study - Mayo Clinic

    The purpose of this research study is to evaluate the long-term safety, and tolerability of PF-06823859 study drug in adult participants with Dermatomyositis ( ...